03/21/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 3/21/2020. This web page, updated on March 21, 2020, provides strategies that the Centers for Disease Control and Prevention (CDC) recommends to prevent the spread of COVID-19 (coronavirus disease) in long-term care facilities and nursing homes. Nursing homes should assume it could already be in their community and move to restrict all visitors and unnecessary healthcare personnel from the facility; cancel group activities and communal dining; and implement active screening of residents and healthcare personnel for fever and respiratory symptoms. (Text)
03/21/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 3/21/2020. There are no Food and Drug Administration (FDA)-approved drugs specifically for the treatment of patients with COVID-19. At present, clinical management includes infection prevention and control measures and supportive care, including supplementary oxygen and mechanical ventilatory support when indicated. An array of drugs approved for other indications, as well as several investigational drugs, are being studied in several hundred clinical trials that are underway across the globe. This web page provides information on two of the approved drugs (chloroquine and hydroxychloroquine) and one of the investigational agents (remdesivir) currently in use in the United States. (Text)
03/21/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 3/21/2020. This COVID-19 (coronavirus) guidance for administration, staff, and volunteers at blood and plasma collection facilities is provided to protect the health of staff, volunteers, and donors by reinforcing adherence to routine infection prevention and control measures, including hand hygiene practices, environmental infection control, and personal protective equipment (PPE); and support and educate staff and volunteers about the symptoms of COVID-19 so that they can evaluate themselves and donors for symptoms and set up the facility to minimize spread. (Text)
03/21/2020 12:00 AM EDT
Source: University of Nebraska Medical Center (UNMC). Published: 3/21/2020. The ongoing pandemic of SARS-CoV-2 resulting in COVID-19 (coronavirus) has severely stressed the worldwide healthcare system and has created dangerous shortages of personal protective equipment (PPE), including N95 filtering facepiece respirators (N95 FFRs). In an effort to extend the stockpile of N95 FFRs, this 20-page document details the decontamination procedure developed by the University of Nebraska Medical Center involving the delivery of ultraviolet germicidal irradiation (UVGI) to used N95 FFRs. (PDF)
03/21/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 3/21/2020. This five-page document provides guidance on infection prevention and control in long-term care facilities in the context of COVID-19, to prevent COVID-19-virus from entering the facility, prevent COVID-19 from spreading within the facility, and prevent COVID-19 from spreading to outside the facility. (PDF)
03/20/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 3/20/2020. This guidance is for owners, administrators, operators, workers, volunteers, visitors, and residents of retirement communities and independent living facilities that are not healthcare facilities. Many people living in retirement communities and independent living facilities are at higher risk of getting very sick from COVID-19 (coronavirus) because they are older adults and/or have serious chronic medical conditions such as heart disease, diabetes, or lung disease. (Text)
03/20/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 3/20/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Xpert Xpress SARS-CoV-2 test, the first emergency use authorization (EUA) for a point-of-care COVID-19 diagnostic. The test is authorized for use on using respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
03/20/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 3/20/2020. This five-page document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It is intended for blood services, national health authorities, and others responsible for the provision of blood and blood components and integration of the blood system within the public health system. (PDF)
03/20/2020 12:00 AM EDT
Source: American College of Occupational and Environmental Medicine (ACOEM). Published: 3/20/2020. In this one-hour, 20-minute webinar, two experienced occupational and environmental medicine professors from Taiwan and Italy discuss how the protection of health care workers (HCWs) has progressed in their country, the number of HCWs infected, and what has worked and not worked in protecting HCWs from COVID-19. (Video or Multimedia)
03/18/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 3/18/2020. The Food and Drug Administration (FDA) has issued this nine-page guidance to provide general considerations to assist sponsors in assuring the safety of trial participants in the conduct of clinical trials of medical products, maintaining compliance with good clinical practice (GCP), and minimizing risks to trial integrity during the COVID-19 (coronavirus) pandemic. It addresses the challenges that may lead to difficulties in meeting protocol-specified procedures, including administering or using the investigational product or adhering to protocol-mandated visits and laboratory/diagnostic testing. (PDF)
03/15/2020 12:00 AM EDT
Source: World Health Organization, Regional Office for Europe. Published: 3/15/2020. This 40-page document aims to assist countries in developing specific plans and/or consolidating further action for prisons and other places of detention in response to the international COVID-19 outbreak, with consideration of preparedness plans, prevention and control strategies, and contingency plans to interface with the wider health and emergency planning system. (PDF)
03/01/2020 12:00 AM EST
Source: National Center for PTSD [Post-Traumatic Stress Disorder] [U.S. Department of Veterans Affairs]. Published: 3/2020. This web page details how well-being and emotional resilience of healthcare workers are key components of maintaining essential healthcare services during the COVID-19 virus (coronavirus) outbreak, and why it is important to fight stress through preparedness and put in place supports for healthcare workers. It discusses how to manage stress during and after the outbreak. (PDF)
03/01/2020 12:00 AM EST
Source: National Center for PTSD [Post-Traumatic Stress Disorder] [U.S. Department of Veterans Affairs]. Published: 3/2020. This web page provides guidance about how health care providers, community and religious leaders, and government officials all have a role to play in helping people cope effectively and manage their stress in the current climate of concerns about COVID-19 (coronavirus) transmission. It describes five key principles for health care providers, community leaders, and others concerned with the psychological welfare of the public to follow when providing help in situations like the COVID-19 outbreak. (Text)
03/01/2020 12:00 AM EST
Source: University of Oxford, Centre for Evidence-Based Medicine (CEBM). Published: 3/2020. The Centre for Evidence-Based Medicine has committed its skills and expertise in evidence synthesis and dissemination to the effort against the current COVID-19 pandemic. Topics in this collection include ACEI and ARBs, weather conditions, conjunctivitis, mobility in isolated elderly, social distancing, management of pneumonia in older people, smoking, fever suppression, inhaled steroids and asthma, NSAIDS, mortality rates, hand disinfectant, and research surveillance. The page will be updated regularly. (Text)
03/01/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 3/2020. This course on COVID-19 at points of entry has three modules: Management of ill travelers at points of entry in the context of the COVID-19 outbreak (available now); Operational considerations for managing COVID-19 cases/outbreak on board ships (coming soon); and Operational considerations for managing COVID-19 cases/outbreak in aviation (coming soon). (Video or Multimedia)
02/18/2020 12:00 AM EST
Source: Australian Government. Published: 2/18/2020. This 56-page document is designed to guide the Australian health sector response to the COVID-19 (coronavirus) pandemic. The strategic objectives across all stages and activities proposed in this plan are to identify and characterize the nature of the virus and the clinical severity of the disease in the Australian context; minimize transmissibility, morbidity, and mortality; minimize the burden on/support health systems; and inform, engage, and empower the public. (PDF)
01/01/2020 12:00 AM EST
Source: Natural Hazards Center [University of Colorado at Boulder]. Published: 1/2020. This training module focuses on culturally competent research, and offers guidance on how hazards and disaster researchers can build cultural competence. It includes three lessons. (Video or Multimedia)
03/18/2019 12:00 AM EDT
Source: World Health Organization (WHO). Published: 3/18/2019. This five-page document provides guidance on COVID-19 cases or outbreaks for any authority involved in public health response to a public health event in aviation, including International Health Regulations (IHR) National Focal Points (NFP); health authorities at airports, local, provincial, and national health surveillance and response systems; as well as civil aviation authorities, airport operators, aircraft operators, airports, and airlines. (PDF)
.png)
No hay comentarios:
Publicar un comentario